Introduction {#section1-1073274819845874}
============

Breast cancer is the most commonly diagnosed cancer among women in the United States, with an estimated 252 710 new breast cancer cases and 40 610 deaths expected in 2017.^[@bibr1-1073274819845874]^ Progress in early detection through mammography and improvements in breast cancer treatment have markedly improved the prognosis for breast cancer, and death rates are now about one-third of the levels in 1990.^[@bibr2-1073274819845874][@bibr3-1073274819845874]-[@bibr4-1073274819845874]^ However, these benefits are not distributed equally across the US population.^[@bibr1-1073274819845874]^ Evidence suggests that Appalachian women experience 7% higher breast cancer mortality compared with non-Appalachian women in the United States, partly due to the higher likelihood of breast cancer being diagnosed at a late stage.^[@bibr5-1073274819845874],[@bibr6-1073274819845874]^

The Appalachian geographic region represents 8% of the US population, an area consisting of 420 contiguous counties spanning 13 states. The National Cancer Institute recognizes the Appalachia region of the United States as a special priority area, given that it represents one of the most economically disadvantaged, and medically underserved regions in the United States.^[@bibr7-1073274819845874][@bibr8-1073274819845874][@bibr9-1073274819845874]-[@bibr10-1073274819845874]^ Several factors have been identified that may explain later stage at diagnosis and higher breast cancer mortality observed among women living in the Appalachian regions of the United States,^[@bibr11-1073274819845874][@bibr12-1073274819845874]-[@bibr13-1073274819845874]^ including lower socioeconomic status and lack of access to health care,^[@bibr9-1073274819845874],[@bibr14-1073274819845874],[@bibr15-1073274819845874]^ lower prevalence of routine mammography, and a lower likelihood to receive recommended treatment for breast cancer.^[@bibr16-1073274819845874][@bibr17-1073274819845874]-[@bibr18-1073274819845874]^

In 2010, the Patient Protection and Affordable Care Act (ACA) was passed by the US Congress to increase health insurance coverage and expand access to health-care services for Americans. In 2014, approximately 64% of the US population was covered through private insurance,^[@bibr19-1073274819845874]^ and this proportion has increased with 6.7 million people newly enrolled in 2014 via the insurance marketplace established under the ACA.^[@bibr20-1073274819845874]^ Although as part of the ACA, states have the option of expanding Medicaid to increase health insurance coverage among low-income and uninsured individuals, participation in the Medicaid expansion provision of the ACA occurred in varying degrees across states.^[@bibr21-1073274819845874][@bibr22-1073274819845874][@bibr23-1073274819845874]-[@bibr24-1073274819845874]^ To date, 31 states including the District of Columbia have expanded Medicaid to low-income adults (individuals with an annual household income \<138% of the federal poverty level) or individuals with qualifying disabilities.^[@bibr25-1073274819845874][@bibr26-1073274819845874]-[@bibr27-1073274819845874]^ In addition to increasing health insurance coverage, ACA also required most health plans to cover preventive health-care serveries without copays or deductibles for A or B-rated recommendations by the US Preventive Services Task Force (USPSTF). In November 2009, the USPSTF issued new age-based recommendations for mammography screening, recommending routine mammography every 2 years for women ages 50 to 74 years.^[@bibr28-1073274819845874]^

Although the ACA and Medicaid expansion has substantially increased health insurance coverage and improved access to health-care services for previously uninsured and low-income Americans,^[@bibr24-1073274819845874]^ the specific impact of the policy on breast cancer screening is still unclear.^[@bibr29-1073274819845874]^ According to a recent review of the literature,^[@bibr29-1073274819845874]^ the lack of consistency in published estimates may be due to limited number of existing studies, methodological limitations, and the fact that most studies examined only a short time period post-ACA. Despite the higher proportion of uninsured and low-income women in Appalachia regions of the United States, few studies have directly evaluated the impact of the ACA Medicaid expansion on breast cancer screening behaviors in this region relative to other parts of the US.^[@bibr11-1073274819845874][@bibr12-1073274819845874]-[@bibr13-1073274819845874]^ The current study aims to examine changes in breast cancer screening before and after ACA Medicaid expansion comparing Appalachia and non-Appalachia states. Results may highlight the impact of health insurance changes due to the ACA on breast cancer screening rates in a historically under-served region, and highlight areas where additional strategies may be needed to narrow existing health disparities.

Methods {#section2-1073274819845874}
=======

Data Source {#section3-1073274819845874}
-----------

Data were obtained from the Centers for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance System (BRFSS). The BRFSS is a representative ongoing, state-based system of landline- and cellular-telephone health surveys.^[@bibr30-1073274819845874],[@bibr31-1073274819845874]^ The BRFSS uses a multistage sampling design to obtain data on self-reported health-related information from non-institutionalized civilian population aged ≥18 years residing in all 50 states, including the District of Columbia and the 3 US territories (Guam, Puerto Rico, and the US Virgin Islands).^[@bibr30-1073274819845874]^ The BRFSS collected data on demographic characteristics, health-related behaviors, chronic health conditions, health-care access, and the use of preventive health services that are associated with the leading causes of death and disability in the United States.^[@bibr30-1073274819845874],[@bibr31-1073274819845874]^ Each year of the BRFSS surveys includes 3 parts: (1) the core component, (2) optional modules, and (3) state-added questions. Since 2000, questions regarding women's health, including history of mammography visits, were asked in even years in all states as part of the BRFSS fixed core questionnaire.

The current study utilizes data for the years 2003 through 2015, and analysis was performed in 2017. As the BRFSS database is a publicly available and deidentified data source, this study was considered exempt by the institutional review board at the University of Kentucky.

Study Variables {#section4-1073274819845874}
---------------

### Outcome {#section5-1073274819845874}

The primary outcome in this study was self-reported mammography screening received in the past 2 years. According to USPSTF recommendations, women aged 50 to 74 years are considered up-to-date if they reported receipt of a mammogram in the previous 2 years.^[@bibr28-1073274819845874]^ Respondents who refused to answer, had a missing response, or answered "don't know/not sure" were excluded from the analyses.

### Main predictors {#section6-1073274819845874}

The independent variables of interest were Appalachia status and state-level Medicaid expansion status. States were defined as Appalachia or non-Appalachia based on the Appalachian Regional Development Act of 1965.^[@bibr32-1073274819845874]^ The Appalachian region includes all of West Virginia and parts of 12 other states including Alabama, Georgia, Kentucky, Maryland, Mississippi, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, and Virginia.^[@bibr32-1073274819845874]^ Medicaid expansion was defined in 2 time periods: pre-expansion (2003-2009) and post-expansion (2011-2015). By the end of the study period of December 31, 2015, a total of 31 states and jurisdictions had implemented the expansion of Medicaid, while 21 states did not implement the policy. The 25 expanded non-Appalachian states and jurisdictions are as follows: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Hawaii, Illinois, Indiana, Iowa, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Jersey, New Mexico, North Dakota, Oregon, Rhode Island, Vermont, US Virgin Islands, and Washington. Among the 13 Appalachia states, 6 states had expanded Medicaid: West Virginia, Kentucky, Maryland, New York, Ohio, and Pennsylvania.

### Study covariates {#section7-1073274819845874}

These included income level (categorized as \<\$10 000, \$10 000-\$20 000, \$20 000-\$50 000, and ≥\$50 000), respondents' age (categorized as 50-59, 60-69, and 70-74 years), race/ethnicity (white, black, Hispanic, other race), education level (\<high school, high school graduate, some college, or ≥college), marital status (married, divorced/widowed/separated, and never married/member of an unmarried couple), and employment status (employed/self-employed, out of work, homemaker, student, retired, or unable to work). Additionally, having a usual health-care provider (at least one provider vs no provider) and having health-care coverage (yes or no) were included. Health coverage includes private insurance, prepaid, and government plans.

Statistical Analysis {#section8-1073274819845874}
--------------------

Descriptive analyses were conducted using χ^2^ tests to compare sociodemographic, socioeconomic, and health-care variables by Appalachia status over the study period. Due to the implementation of the ACA Medicaid expansion in 2010, calendar year 2010 was considered as the washout period. To determine whether there were differences in mammography screening between expanded and nonexpanded states across the study periods, multivariable logistic regression models with generalized estimating equations were used to interpret odds ratios as relative risks after adjusting for age-group, race/ethnicity, annual household income, education, and employment. Subgroup analysis for age groups and among women with annual household income ≤\$20 000 was also conducted. Analyses were weighted using appropriate survey procedures to account for the complex sample survey design. Results were presented as risk ratios and 95% confidence intervals (CIs), and *P* values of \<.05 were considered statistically significant. All analyses were conducted using SAS 9.4 (SAS Institute, Cary, North Carolina).

Results {#section9-1073274819845874}
=======

A total of 1 112 972 female participants were included in this analysis: 808 700 (73%) in non-Appalachia states and 304 272 (27%) in Appalachia states ([Table 1](#table1-1073274819845874){ref-type="table"}). [Table 1](#table1-1073274819845874){ref-type="table"} shows the baseline characteristics of the study participants overall and by Appalachia status. Overall, the majority of participants were white (82%), about 60% had some college degree or higher, 39% had an annual household income of greater than \$50 000, and 91% had health insurance coverage. Compared to the non-Appalachia states, participants in Appalachia states were more likely to be black (16% vs 6%), have less than a high school education (12% vs 8%), have an average annual household income of \<\$10 000 (8% vs 6%), and more likely to have no health insurance coverage (9% vs 8%).

###### 

Baseline Characteristics of Study Population by Non-Appalachian and Appalachian States Study, BRFSS 2003 to 2015.^a^

![](10.1177_1073274819845874-table1)

  Study Characteristics              Total (N = 1 112 972)   Non-Appalachian (39 States; n = 808 700)   Appalachia (13 States; n = 304 272)   *P* Value
  ---------------------------------- ----------------------- ------------------------------------------ ------------------------------------- -----------
  Sociodemographics                                                                                                                           
   Age (years)                                                                                                                                
    50-59                            494 433 (43.14)         361 408 (35.67)                            133 025 (32.54)                       \<.0001
    60-69                            442 250 (40.77)         319 808 (32.9)                             122 442 (31.55)                       
    70-74                            176 289 (16.07)         386 707 (31.41)                            139 531 (35.9)                        
   Race                                                                                                                                       
    White                            909 798 (82.09)         670 643 (83.75)                            239 155 (79.7)                        \<.0001
    Black                            94 905 (8.86)           46 669 (5.86)                              48 236 (16.0)                         
    Hispanic                         48 703 (4.51)           43 225 (5.32)                              5478 (1.77)                           
    Other race                       49 646 (4.53)           41 591 (5.04)                              8055 (2.51)                           
  Socioeconomic status                                                                                                                        
   Education                                                                                                                                  
    \<High school                    102 473 (8.65)          63 887 (7.48)                              38 586 (11.80)                        \<.0001
    High school graduate             357 236 (31.57)         248 265 (30.08)                            108 971 (35.56)                       
    Some college or higher           650 458 (59.77)         494 462 (62.43)                            155 996 (52.63)                       
   Income level                                                                                                                               
    \<\$10 000                       60 865 (6.28)           40 738 (5.87)                              20 127 (7.81)                         \<.0001
    \$10 000-\<\$20 000              145 238 (15.15)         98 677 (16.0)                              46 571 (14.01)                        
    \$20 000-\<\$50 000              375 324 (39.07)         276 858 (41.7)                             98 466 (40.87)                        
    ≥50 000                          357 676 (39.49)         272 688 (36.4)                             85 008 (31.0)                         
   Employment                                                                                                                                 
    Employed                         423 881 (37.79)         317 535 (38.97)                            106 346 (34.64)                       \<.0001
    Self-employed                    77 778 (6.94)           61 787 (7.60)                              15 991 (5.18)                         
    Unemployed                       47 178 (4.60)           34 529 (4.62)                              12 649 (4.53)                         
    Student/homemaker/retired        452 968 (40.64)         323 448 (39.97)                            129 520 (42.46)                       
    Unable to work                   107 396 (10.01)         68 567 (8.82)                              38 829 (13.17)                        
   Marital status                                                                                                                             
    Married                          595 763 (53.7)          437 974 (54.33)                            157 789 (52.0)                        \<.0001
    Divorced/widowed/separated       428 150 (38.27)         304 807 (37.50)                            123 343 (40.32)                       
    Never married/unmarried couple   84 359 (8.03)           62 420 (8.16)                              21 939 (7.66)                         
  Health-care access                                                                                                                          
   Health-care coverage^b^                                                                                                                    
    Yes                              1 015 004 (91.38)       739 064 (91.60)                            275 940 (90.80)                       \<.0001
    No                               96 274 (8.62)           68 450 (8.40)                              27 824 (9.20)                         
   Health-care providers^c^                                                                                                                   
    At least one                     1 022 562 (92.22)       739 552 (91.84)                            283 010 (93.23)                       \<.0001
    No                               87 852 (7.78)           67 132 (8.16)                              20 720 (6.76)                         

Abbreviation: BRFSS, Behavioral Risk Factor Surveillance System.

^a^Values in parenthesis denote row percentage. Appalachia states include Alabama, Georgia, Kentucky, Maryland, Mississippi, New York, Ohio, North Carolina, Pennsylvania, South Carolina, Tennessee, Virginia, and, West Virginia.

^b^Health-care coverage is defined as having any kind of health-care coverage, including health insurance, prepaid plans such as HMOs, or government plans such as Medicare.

^c^Health-care providers are defined as personal doctor or health-care provider.

[Table 2](#table2-1073274819845874){ref-type="table"} presents the prevalence of mammography screening in the past two years by socio-demographic, socio-economic and healthcare access variables.

###### 

Breast Cancer Screening in Appalachian Versus Non-Appalachian States by Expansion Status Among Women Aged 50 to 74 Years During Study Period, BRFSS 2003 to 2015.^a^

![](10.1177_1073274819845874-table2)

  Characteristics              Breast Cancer Screening^b^                                                                 
  ---------------------------- ---------------------------- ----------------- --------- ---------------- ---------------- ---------
  Overall                      80.87                        84.23                       83.81            83.48            
  Sociodemographics                                                                                                       
   Age (years)                                                                                                            
    50-59                      58 775 (79.41)               93 977 (82.96)    \<.0001   32 819 (82.80)   26 187 (82.33)   \<.0001
    60-69                      55 728 (81.75)               85 751 (85.20)              31 593 (84.14)   24 100 (84.41)   
    70-74                      23 392 (82.39)               32 834 (85.18)              12 744 (85.45)   9267 (84.25)     
   Race                                                                                                                   
    White                      118 281 (80.87)              173 003 (84.3)    \<.0001   57 111 (83.22)   50 158 (83.02)   \<.0001
    Black                      7822 (85.93)                 13 226 (86.99)              16 231 (86.44)   6140 (88.39)     
    Hispanic                   5848 (79.55)                 11 778 (83.86)              1091 (83.27)     1265 (85.20)     
    Other race                 5105 (75.71)                 12 769 (81.42)              1928 (79.38)     1408 (78.59)     
  Socioeconomic status                                                                                                    
   Income level                                                                                                           
    \<\$10 000                 6117 (70.63)                 8737 (74.47)      \<.0001   4744 (75.16)     2927 (74.31)     \<.0001
    \$10 000-\<\$20 000        16 278 (72.31)               20 934 (75.77)              11 247 (76.62)   7355 (74.80)     
    \$20 000-\<\$50 000        49 597 (79.81)               68 434 (82.59)              25 133 (84.03)   19 749 (82.85)   
    ≥\$50 000                  45 530 (86.23)               83 921 (88.54)              21 999 (89.27)   20 255 (88.29)   
   Education                                                                                                              
    \<High school              10 263 (74.14)               14 057 (79.54)    \<.0001   9978 (77.42)     5151 (77.58)     \<.0001
    High school graduate       44 915 (79.44)               59 683 (82.76)              25 934 (82.67)   21 812 (82.21)   
    Some college or higher     82 527 (82.52)               138 531 (85.3)              41 134 (86.11)   32 508 (85.27)   
   Employment                                                                                                             
    Employed                   53 780 (82.07)               87 192 (85.56)    \<.0001   26 443 (85.65)   23 190 (85.39)   \<.0001
    Self-employed              9557 (74.49)                 15 209 (79.49)              3775 (79.34)     3096 (79.22)     
    Unemployed                 4252 (69.89)                 8494 (76.01)                2774 (73.77)     2076 (75.76)     
   Student/homemaker/retired   58 947 (83.40)               85 670 (86.39)              34 208 (85.87)   25 101 (85.08)   
    Unable to work             11 052 (74.34)               15 593 (76.91)              9817 (78.09)     5966 (76.03)     
  Health-care access                                                                                                      
   Health-care coverage                                                                                                   
    Yes                        128 764 (83.14)              202 318 (85.94)   \<.0001   71 668 (86.03)   56 402 (85.19)   \<.0001
    No                         8943 (57.75)                 9984 (59.69)                5361 (62.39)     3074 (60.89)     
   Health-care providers                                                                                                  
    At least one               130 272 (83.20)              203 028 (86.25)   \<.0001   73 389 (85.60)   57 604 (84.97)   \<.0001
    No                         7406 (53.60)                 9268 (55.29)                3651 (58.65)     1865 (53.57)     

Abbreviations: ACA, Affordable Care Act; BRFSS, Behavioral Risk Factor Surveillance System.

^a^N = 582 381. Expanded states include AR, AZ, CA, CO, CT, DE, HI, IA, IL, KY, MD, MA, MI, MN, NV, NH, NJ, NM, NY, ND, OH, OR, PA, RI, VT, WA, WV, and DC which expanded Medicaid under the ACA between 2010 and 2015. Nonexpanded states did not expand Medicaid under the ACA till the end of 2015.

^b^Breast cancer screening is defined as women respondents aged 50 to 74 who have had a mammogram in the past 2 years (USPSTF 2009).

Overall, 82% of study participants had received a mammogram in the past 2 years, 83% in Appalachia states and 82% in non-Appalachia states. In non-Appalachia states, mammography screening was higher in expanded (84%) versus nonexpanded (81%) states overall, regardless of sociodemographic characteristics. For instance, among women ages 50 to 59, screening prevalence was 83% in expanded states compared with 79% in nonexpanded states. In addition, screening was higher among whites (84% vs 81%), and Hispanics (84% vs 79%) in expanded versus nonexpanded states. Screening was lowest among women with no regular health-care provider in both expanded (55%) and non-expanded (54%) non-Appalachia states and highest among those with annual household income \>\$50 000. In Appalachia states, there were only modest differences in screening prevalence between expanded and non-expanded states. For instance, 82% of women ages 50 to 59 years were screened in expanded Appalachian states, compared with 83% in non-expanded Appalachian states. Similar to non-Appalachia states, screening was highest among women with annual household income \>\$50 000 and lowest among women with no regular health-care provider.

As shown in [Table 3](#table3-1073274819845874){ref-type="table"}, screening was marginally higher in Appalachia non-expanded versus expanded states in the pre-expansion (2003-2009; relative risk \[RR\]: 1.002, 95% CI: 1.002-1.003) and postexpansion periods (2011-2015; RR: 1.001, 95% CI: 1.001-1.002) after adjusting for study covariates.

###### 

Relative Risks for Breast Cancer Screening by Medicaid Expansion Status and Age-Group, US BRFSS 2003 to 2015.^a^

![](10.1177_1073274819845874-table3)

  Year           Breast Cancer Screening                                                          
  -------------- -------------------------- -------------------------- -------------------------- ---------------------------
  Overall US                                                                                      
   Expanded      30 832 (84.49)             15 817 (82.59)             120 100 (85.28)            46 028 (83.38)
   Nonexpanded   47 801 (84.92)             15 037 (82.61)             76 145 (82.97)             27 446 (79.54)
                 RR = 1.002 (1.002-1.003)   RR = 1.001 (1.001-1.002)   RR = 0.978 (0.978-0.979)   RR = 0.958 (0.955-0.959)
  50-59 years                                                                                     
   Expanded      14 265 (83.71)             6468 (81.05)               56 043 (84.20)             18 539 (81.81)
   Nonexpanded   21 404 (84.03)             5757 (81.12)               34 218 (81.64)             10 916 (78.13)
                 RR = 1.004 (1.00-1.008)    RR = 1.005 (1.004-1.006)   RR = 0.975 (0.974-0.976)   RR = 0.961 (0.960-0.962)
  60-69 years                                                                                     
   Expanded      11 829 (84.94)             6817 (83.69)               46 100 (86.12)             19 888 (84.57)
   Nonexpanded   18 901 (85.35)             6632 (83.31)               29 401 (83.87)             11 727 (80.30)
                 RR = 1.005 (1.005-1.006)   RR = 0.996 (0.995-0.997)   RR = 0.981 (0.979-0.982)   RR = 0.956 (0.955-0.957)
  70-74 years                                                                                     
   Expanded      4738 (85.77)               2532 (83.72)               17 957 (86.47)             7601 (84.25)
   Nonexpanded   7496 (86.36)               2648 (84.22)               12 526 (84.49)             4803 (80.97)
                 RR = 0.99 (0.989-1.00)     RR = 1.012 (1.011-1.013)   RR = 0.98 (0.979-0.981)    RR = 0.961 (0.9609-0.962)

Abbreviations: ACA, Affordable Care Act; BRFSS, Behavioral Risk Factor Surveillance System; Reference = Expanded; RR, relative risk.

^a^Excluded 2010 data as the washout period. RRs for age categories have been adjusted for race, annual household income, and educational status using Proc Genmod.

In non-Appalachia states, screening was lower in non-expanded states versus expanded states in pre-expansion (RR: 0.978, 95% CI: 0.978-0.979) and postexpansion periods (RR: 0.958, 95% CI: 0.955-0.959). Stronger associations were observed in the 50-59 years and 60-69 years age groups ([Table 3](#table3-1073274819845874){ref-type="table"}). Among expanded states, there was 5% lower screening (RR: 0.956, 95% CI: 0.949-0.957) in the post versus pre-expansion period, while non-expanded states had 3% lower screening (RR: 0.970, 95% CI: 0.969-0.978) in the post-expansion versus pre-expansion period ([Table 4](#table4-1073274819845874){ref-type="table"}).

###### 

Relative Risks for Breast Cancer Screening for Overall and Low-Income Women by Expansion and Time Period, US BRFSS 2003 to 2015.^a^

![](10.1177_1073274819845874-table4)

  Expansion status             Overall^b^            Low Income^c^ (≤\$20 000)^d^                         
  ---------------------------- --------------------- ------------------------------ --------------------- ---------------------
  Expanded                                                                                                
   Pre-expansion (2003-2009)   Ref                   Ref                            Ref                   Ref
   Postexpansion (2011-2015)   0.972 (0.969-0.973)   0.956 (0.949-0.957)            0.961 (0.959-0.961)   0.937 (0.936-0.938)
  Nonexpanded                                                                                             
   Pre-expansion (2003-2009)   Ref                   Ref                            Ref                   Ref
   Postexpansion (2011-2015)   0.970 (0.969-0.971)   0.978 (0.969-0.978)            0.972 (0.969-0.973)   0.978 (0.977-0.979)

Abbreviations: BRFSS, Behavioral Risk Factor Surveillance System; CI, confidence interval; RR, relative risk.

^a^Relative risks were adjusted for sex, race, annual household income, educational status including interaction terms for expansion status and time periods of pre- and postexpansion using Proc Genmod. Excluded 2010 data as the washout period.

^b^ *P* value for expand × period interaction: \<.0001.

^c^ *P* value for expand × period interaction: .0019.

^d^Annual household income ≤\$20 000.

In subgroup analysis by age group and household income ≤\$20 000 ([Table 4](#table4-1073274819845874){ref-type="table"}), there was a 3% decline in screening post- versus pre-expansion (RR: 0.972, 95% CI: 0.969-0.973) in Appalachia, and in non-Appalachia, there was a 5% (RR: 0.956, 95% CI: 0.949-0.957) and 3% (RR: 0.978, 95% CI: 0.969-0.978) decline post- versus pre-expansion in expanded states and nonexpanded states, respectively. Similar declines were observed among low-income participants (annual household income ≤\$20 000).

Discussion {#section10-1073274819845874}
==========

In a large nationally representative study population of women aged 50-74 years in Appalachia and non-Appalachia US states, this study examined the impact of ACA Medicaid expansion on breast cancer screening pre- and post-expansion. Results showed that 83% of women in Appalachia states self-reported breast cancer screening in the past 2 years, compared with 82% of women in non-Appalachia states. Overall in Appalachia states, there were negligible differences in screening prevalence comparing expanded and non-expanded states; however, in non-Appalachia states, screening prevalence was significantly higher in expanded compared with non-expanded states. In adjusted models, screening in Appalachia states was marginally higher in non-expanded states compared with expanded states in both pre- and post-expansion periods. However, within expanded and non-expanded Appalachia states, screening declined in the post- versus pre-expansion period. In non-Appalachia states, screening was lower in non-expanded states compared with expanded states in both pre- and post-expansion periods, and within expanded and non-expanded states, screening declined in the post-expansion period compared with pre-expansion period.

Previous studies have examined the impact of Medicaid expansion on self-reported breast cancer screening among US adults.^[@bibr3-1073274819845874],[@bibr26-1073274819845874],[@bibr33-1073274819845874][@bibr34-1073274819845874][@bibr35-1073274819845874][@bibr36-1073274819845874][@bibr37-1073274819845874][@bibr38-1073274819845874][@bibr39-1073274819845874]-[@bibr40-1073274819845874]^ Similar to our findings, other studies have observed significant reductions in breast cancer screening in the post-expansion period.^[@bibr26-1073274819845874],[@bibr34-1073274819845874][@bibr35-1073274819845874]-[@bibr36-1073274819845874],[@bibr39-1073274819845874]^ Two US studies^[@bibr26-1073274819845874],[@bibr36-1073274819845874]^ found a 13%^[@bibr26-1073274819845874]^ and 20%^[@bibr36-1073274819845874]^ reduced odds of breast cancer screening in the post-expansion period among women aged 50 to 74 years. We observed that in non-expanded Appalachia states, women aged 50 to 59 years had marginally higher screening in both the pre- and post-expansion periods. However, among women aged 60 to 69 years, screening was marginally higher in the pre-expansion compared to the post-expansion period, but was marginally higher among women aged 70 to 74 years higher in the postexpansion compared to the pre-expansion period.

In non-expanded non-Appalachia states, screening was lower across all the age groups consistently in the post-expansion compared to the pre-expansion period. In the pre-expansion period, screening was lowest among women aged 50 to 59 years, while in the postexpansion period, screening was lowest among women aged 60 to 69 years.

A previous study also reported a 28% reduction in screening during 2009 to 2010 compared with 2004 to 2005 using the Medical Expenditure Panel Survey.^[@bibr37-1073274819845874]^ Two cross-sectional studies using the BRFSS found higher prevalence of self-reported mammography in the expanded states of 5%^[@bibr33-1073274819845874]^ and 3%^[@bibr40-1073274819845874]^ in 2012 and 2014, respectively, and a separate study observed that among low-income women, screening rates were 8% higher in expanded states compared to nonexpanded states.^[@bibr40-1073274819845874]^ Our study adds more recent, empirical data regarding the impact of Medicaid expansion on breast cancer screening in the United States and reveals that, in general, there were declines in breast cancer screening in the post-ACA period in both expanded and non-expanded states, regardless of Appalachia status. There are several possible reasons for these observations, including state-level differences in Medicaid expansion eligibility and requirements, lack of information regarding insurance benefits, confusion about changing guidelines regarding appropriate timing and frequency of screening, or lack of health-care provider recommendation.

First, we observed the lowest breast cancer screening prevalence among women with no regular health-care provider (55% in expanded non-Appalachia states; 54% in non-expanded non-Appalachia states, 54% in expanded Appalachia states; and 59% in non-expanded Appalachia states), suggesting that lack of provider recommendation remains a strong predictor of routine screening regardless of expansion or Appalachia status, as shown in previous studies.^[@bibr41-1073274819845874][@bibr42-1073274819845874][@bibr43-1073274819845874]-[@bibr44-1073274819845874]^ Second, while the ACA aimed to provide free or reduced cost coverage for screening services that were previously not available and/or affordable, some studies have reported significant administrative barriers that reduced utilization of this benefit, such as out-of-network fees or restrictions on grandfathered plans.^[@bibr34-1073274819845874]^ In addition, insurance coverage through the ACA may not necessarily guarantee receipt of those services.^[@bibr45-1073274819845874]^ States were given latitude to establish their own Medicaid eligibility requirements and reimbursements, and given significant variation in eligibility and administrative requirements across states in Medicaid programs,^[@bibr21-1073274819845874][@bibr22-1073274819845874][@bibr23-1073274819845874]-[@bibr24-1073274819845874]^ utilization of the benefit for preventive care, including breast cancer screening, may be negatively affected. Further, according to the Kaiser Family Foundation, awareness of the provisions of the ACA policy remains low; in a 2014 poll, only 43% of Americans were aware of the free preventive health-care benefits available as part of the ACA.^[@bibr20-1073274819845874]^

Third, a recent study observed that despite the availability of screening services, most of the women in the target population are not screened due to lack of knowledge of screening guidelines or transportation issues and lack of providers in proximity,^[@bibr46-1073274819845874]^ suggesting that lack of access to health care, independent of insurance status, remains a significant barrier to breast cancer screening. Future studies are needed to better target these disparate populations and address barriers to health-care access. Fourth, while self-reported measures of women's cancer screening in the BRFSS have been validated^[@bibr47-1073274819845874],[@bibr48-1073274819845874]^ as we and others have shown that^[@bibr34-1073274819845874][@bibr35-1073274819845874][@bibr36-1073274819845874]-[@bibr37-1073274819845874],[@bibr39-1073274819845874]^ self-reported measures of breast cancer screening are subject to recall bias^[@bibr49-1073274819845874]^ resulting in misclassification, with a significant proportion of participants overreporting screening practices. Data using objective measures of screening from claims data across Medicaid expansion and Appalachia states may be necessary to definitively estimate the impact of the ACA on breast cancer screening in the United States.

There were certain limitations relevant to this study. First, given that breast cancer screening information in the BRFSS are only assessed in the BRFSS in even years, we were able to analyze only 2 years of data for 2012 and 2014 in the ACA Medicaid post-expansion period, which may be too short to fully capture the influence of ACA expansion on screening. Future studies based on a longer follow-up period from ACA expansion will help to further clarify these findings. Also, we were unable to assess screening among respondents based on the type of insurance, duration of the insurance, and also if the type of insurance was adequate to cover screening services. The BRFSS asked whether respondents have insurance but not type of coverage (Medicaid, Medicare, or private); therefore, we were unable to compare differences based on insurance types. Second, in 2010, the BRFSS introduces a new weighting method, which replaced the poststratification method with raking (iterative proportional fitting).^[@bibr50-1073274819845874]^ According to the CDC, comparison between years before and after these changes may have been affected.^[@bibr50-1073274819845874]^ We examined the trends in the pre-expansion period (2003-2009) and postexpansion periods (2011-2015) by categorizing expanded and nonexpanded states and examining the trends while considering calendar year 2010 as our washout period. Another methodological change in 2011 was the addition of cell phone numbers along with landline telephones numbers to administer the BRFSS survey, while prior surveys utilized landline telephone numbers exclusively. Third, evaluation of the impact of the ACA Medicaid expansion policy on breast cancer screening may be vulnerable to ecological bias; however, this approach is used extensively to assess state-wide health policies, and we utilized statistically rigorous approaches to our analysis, including comparing pre- and postexpansion screening rates among expanded and nonexpanded states and utilizing multivariable adjusted regression models to account for study covariates.

This study addresses several of the gaps in previous literature on this topic. Specifically, we compared expansion status based on Appalachia status. Prior studies have shown that women in Appalachia regions have much lower breast cancer screening rates and significantly higher mortality rates compared to the national average,^[@bibr11-1073274819845874],[@bibr16-1073274819845874]^ although none of the prior studies have evaluated the role of ACA expansion in this region. Second, the analysis evaluated differences in screening rates by pre- and post-expansion status. Other studies have only evaluated differences in screening postexpansion only, without accounting for baseline screening levels.^[@bibr26-1073274819845874],[@bibr40-1073274819845874]^ Also, our analyses include a large sample size, racial and socio-economically diverse study population, and a nationally representative source of data that enhances generalizability, while the use of standardized interview questions across all the survey years that enhances the reliability of our main study measure.

In summary, breast cancer screening rates were higher in Appalachia versus non-Appalachia US states, and higher in expanded versus nonexpanded non-Appalachia states. There were also modest declines in breast cancer screening rates in the post-expansion period regardless of expansion and Appalachia status, suggesting that more work is needed to reduce administrative, logistical, and structural barriers to breast cancer screening services for US women.
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